对于多线治疗(包括移植及CD19/CD22 CAR-T细胞)后的R/R B-ALL患者,两剂CD22抗体方案疗效好、费用低,肝毒性和HVOD发生率低。. The gene discussed is CD22; the disease is acute lymphoblastic leukemia.